At the 2016 Advances in Neuroblastoma Research meeting, CRI Director Sam Volchenboum presented a demo of the International Neuroblastoma Risk Group (INRG) Data Commons. The Data Commons, built by a UChicago team including the Center for Research Informatics and Center for Data Intensive Science, brings together phenotypic information and genomic data related to neuroblastoma. Researchers can perform complex cohort discovery, then conduct genomic analysis in a secure, high-performance environment. To learn more about how the Data Commons works, watch Sam’s demo above.
The CRI’s instance of REDCap has been upgraded to version 6.14.0. The newest features are:
• Responsive Design of Web Pages
• Live Filters for Reports
• New Action Tag @USERNAME
• New Action Tag @DEFAULT
• CDISC ODM (XML) Export
CRI will upgrading to the latest version of REDCap on Tuesday, June 21st. REDCap will be unavailable on from 3 pm – 5pm. REDCap surveys and the mobile app will be unavailable as well. Communication will go out when REDCap is available again. Please contact REDCap Support with any questions. Thank you.
The University of Chicago has publicly launched the National Cancer Institute’s Genomic Data Commons, developed by Chief Research Informatics Officer Bob Grossman. Representing two years of work by Dr. Grossman’s Center for Data Intensive Science and the CRI’s Bioinformatics Core, the GDC brings together genomic and clinical cancer data from multiple sources on a unified platform. Data that was formerly available only piecemeal is now centralized and standardized, making large datasets for cancer research far more accessible to scientists. The GDC is not only an unprecedentedly large repository of this data, it is also linked to tools for analysis and data sharing. Read more about the GDC here.
Vice President Joe Biden announced the GDC’s launch as part of the National Cancer Moonshot Initiative. By democratizing access to data and analysis tools and making it easier for researchers to collaborate, the GDC will contribute significantly to this effort to improve prevention, diagnosis, and treatment of cancer. The CRI is proud to have contributed bioinformatics expertise and resources to this important effort. Learn more about our contribution here.